IP Library Granted Patent US 10,238,848
Granted Patent B2
US 10,238,848 · App. 14/789,919 · Granted Mar 26, 2019

Solvent-cast microprotrusion arrays containing active ingredient

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,238,848
App. No.
14/789,919
Granted
Mar 26, 2019
Kind
B2
Abstract

In an aspect of the invention, an array of microprotrusions is formed by providing a mold with cavities corresponding to the negative of the microprotrusions, casting atop the mold a first solution comprising a biocompatible material and a solvent, removing the solvent, casting a second solution atop the first cast solution, removing the solvent from the second solution, and demolding the resulting array from the mold. The first solution preferably contains an active ingredient.

Claims (19)

1. A microprotrusion array, comprising:

an approximately planar base and a plurality of microprotrusions, wherein the microprotrusions comprise at least a first and a second layer arranged roughly parallel to the plane of the planar base, the first and second layers formed of different polymers, the first layer is contained in a distal end of the microprotrusions and comprised of (i) a biodegradable polymer, (ii) one or more components to facilitate biodegradation selected from sugars, sugar alcohols, cyclodextrins and water-swellable polymers, and (iii) an active ingredient, wherein a ratio of weight percent of the biodegradable polymer to weight percent of the one or more components to facilitate biodegradation is in the range of about 6.25:1 to about 1:3.75.

2. The array of claim 1 , wherein the second layer is comprised of a polymer that is biodegradable.

3. The array of claim 1 , wherein at least the first layer comprises at least one of polyvinyl alcohol, dextran, and hydroxyethyl starch.

4. The array of claim 1 , wherein the sugar is selected from dextrose, fructose, galactose, maltose, maltylose, iso-maltulose, mannose, lactose, lactulose, sucrose and trehalose.

5. The array of claim 1 , wherein the sugar alcohol is selected from sorbitol, lactitol, malitol or mannitol.

6. The array of claim 1 , wherein at least the first layer comprises at least one antioxidant.

7. The array of claim 6 , wherein the antioxidant is selected from methionine, cysteine, D-alpha tocopherol acetate, DL-alpha tocopherol, ascorbyl palmitate, ascorbic acid, butylated hydroxyanisole, butylated hydroxyquinone, hydroxycomarin, butylated hydroxytoluene, cephalin, ethyl gallate, propyl gallate, octyl gallate, lauryl gallate, propylhydroxybenzoate, trihydroxybutyrophenone, dimethylphenol, ditertbutylphenol, vitamin E, lecithin or ethanolamine.

8. The array of claim 1 , wherein at least one of the first and second layers comprises an antimicrobial.

9. The array of claim 8 , wherein the antimicrobial is chosen from the group consisting of benzalkonium chloride, benzyl alcohol, chlorbutanol, meta cresol, esters of hydroxyl benzoic acid, phenol, and thimerosal.

10. The array of claim 1 , wherein a layer of the first and second layers comprises cellulose acetate butyrate, cellulose acetate, cellulose acetate propionate, ethyl cellulose, nitrocellulose, hydroxypropyl methyl cellulose phthalate, a polyacrylate, a polymethacrylate, a poly(hydroxyl alkanoate), poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acid), a polycaprolactone, or copolymers thereof.

11. The array of claim 1 , wherein the active ingredient comprises a polypeptide, a protein, or a nucleic acid.

12. The array of claim 11 , wherein the active ingredient is selected from a vaccine, a therapeutic antibody or parathyroid hormone.

13. The array of claim 1 , wherein the array achieves a skin penetration efficiency of at least about 80%.

14. The array of claim 1 , wherein at least one microprotrusion has a cross sectional diameter in a plane parallel to that of the base which decreases as a function of the distance of the plane parallel from the base in such a way that the cross sectional diameter decreases more rapidly near the base than further away from it.

15. The array of claim 1 , wherein at least some of the microprotrusions detach from the base following insertion into skin.

16. The array of claim 1 , wherein the rate at which portions of the microprotrusions degrade is dependent on the pH of the environment in which the portions of the microprotrusions find themselves following insertion.

17. The array of claim 1 , wherein the first layer comprises a composition which degrades at different rates at different temperatures in the range of about 25° C. to about 40° C.

18. The array of claim 1 , wherein the biodegradable polymer in the first layer is dextran, the component to facilitate biodegradation is sorbitol, and the active ingredient is parathyroid hormone.

Assignments (9)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 61852 FRAME: 207. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 30, 2025
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 071915/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2022
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 062760/0731 →
RELEASE OF SECURITY INTEREST Recorded Oct 19, 2022
From: HERCULES CAPITAL, INC., AS AGENT
To: CORIUM, INC.
Reel/Frame 061713/0557 →
RELEASE OF SECURITY INTEREST Recorded Oct 17, 2022
From: HERCULES CAPITAL, INC.
To: CORIUM, INC.
Reel/Frame 061687/0281 →
SECURITY INTEREST Recorded Oct 17, 2022
From: CORIUM PHARMA SOLUTIONS, INC.
To: SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 061689/0581 →
CHANGE OF NAME Recorded Oct 14, 2022
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 061852/0207 →
SECURITY INTEREST Recorded Sep 24, 2021
From: CORIUM, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 057597/0907 →
CHANGE OF NAME Recorded Apr 9, 2019
From: CORIUM INTERNATIONAL, INC.
To: CORIUM, INC.
Reel/Frame 048841/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2018
From: SINGH, PARMINDER; WORSHAM, ROBERT WADE; TRAUTMAN, JOSEPH C.; BAYRAMOV, DANIR; BOWERS, DANNY LEE; KLEMM, ANDREW RICHARD; KLEMM, STEVEN RICHARD; CHEN, GUOHUA
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 047344/0603 →
Cited By (2)
US 12,636,250 US 12,708,750